Re: [yang-doctors] [OPSAWG] Yangdoctors early review of draft-ietf-opsawg-sap-02

mohamed.boucadair@orange.com Fri, 25 March 2022 06:54 UTC

Return-Path: <mohamed.boucadair@orange.com>
X-Original-To: yang-doctors@ietfa.amsl.com
Delivered-To: yang-doctors@ietfa.amsl.com
Received: from localhost (localhost [127.0.0.1]) by ietfa.amsl.com (Postfix) with ESMTP id 3E9C93A0CDC; Thu, 24 Mar 2022 23:54:08 -0700 (PDT)
X-Virus-Scanned: amavisd-new at amsl.com
X-Spam-Flag: NO
X-Spam-Score: -2.106
X-Spam-Level:
X-Spam-Status: No, score=-2.106 tagged_above=-999 required=5 tests=[BAYES_00=-1.9, DKIM_SIGNED=0.1, DKIM_VALID=-0.1, DKIM_VALID_AU=-0.1, DKIM_VALID_EF=-0.1, RCVD_IN_MSPIKE_H4=0.001, RCVD_IN_MSPIKE_WL=0.001, SPF_HELO_NONE=0.001, SPF_PASS=-0.001, T_SCC_BODY_TEXT_LINE=-0.01, UNPARSEABLE_RELAY=0.001, URIBL_BLOCKED=0.001] autolearn=ham autolearn_force=no
Authentication-Results: ietfa.amsl.com (amavisd-new); dkim=pass (2048-bit key) header.d=orange.com
Received: from mail.ietf.org ([4.31.198.44]) by localhost (ietfa.amsl.com [127.0.0.1]) (amavisd-new, port 10024) with ESMTP id dktf0g19fhje; Thu, 24 Mar 2022 23:54:03 -0700 (PDT)
Received: from relais-inet.orange.com (relais-inet.orange.com [80.12.66.41]) (using TLSv1.2 with cipher ECDHE-RSA-AES128-GCM-SHA256 (128/128 bits)) (No client certificate requested) by ietfa.amsl.com (Postfix) with ESMTPS id 05C903A0CE8; Thu, 24 Mar 2022 23:54:02 -0700 (PDT)
Received: from opfedar06.francetelecom.fr (unknown [xx.xx.xx.8]) (using TLSv1.3 with cipher TLS_AES_256_GCM_SHA384 (256/256 bits) key-exchange X25519 server-signature RSA-PSS (2048 bits)) (No client certificate requested) by opfedar25.francetelecom.fr (ESMTP service) with ESMTPS id 4KPt9P3YrZz8tNW; Fri, 25 Mar 2022 07:54:01 +0100 (CET)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=orange.com; s=ORANGE001; t=1648191241; bh=I8hFevY6hbaSG13xNgYSxuF1ZaF87xXEp7/uRIOlNWk=; h=From:To:Subject:Date:Message-ID:Content-Type: Content-Transfer-Encoding:MIME-Version; b=iXQwbWMFogOTVUd2J+QePWiqIw+6uymgsZ+2pQcToSrluaB8xzs03iu4V2bEJzWC2 p1jsjnEzFUoS9HLzjI4zp/LVD0WIiczNpRloJvq1d+sow4ug3wtT3gnTil5ggj2YO2 TyzrzDoxnlXFgFPxayU4Da9tv5+1XxkbaChk+xN4fdhO8X7D39m790M5AmWYy//3ft kXxsHS427svgIWKE4GsX727tsnIATDTFOyMIi+RxJydGl8nuzyMZFcFVkpJWlJE2+r eUgqg+aH0/+eDxp3GSmT54cVBlZrjZLybvKHz8sb2z9JS7lhRrJR4Lqybmeabv5h76 g6BdO0dXp3sLQ==
From: mohamed.boucadair@orange.com
To: Martin Björklund <mbj+ietf@4668.se>
CC: "yang-doctors@ietf.org" <yang-doctors@ietf.org>, "draft-ietf-opsawg-sap.all@ietf.org" <draft-ietf-opsawg-sap.all@ietf.org>, "opsawg@ietf.org" <opsawg@ietf.org>
Thread-Topic: [OPSAWG] Yangdoctors early review of draft-ietf-opsawg-sap-02
Thread-Index: AQHYMwBwyoa88EE4f0KnfSQRz/V79Ky1p/0AgBobggA=
Content-Class:
Date: Fri, 25 Mar 2022 06:54:00 +0000
Message-ID: <20123_1648191241_623D6709_20123_257_1_0a77710be9954fb598ae983f1d69bf90@orange.com>
References: <164672897886.31783.14591417824329563924@ietfa.amsl.com> <30596_1646735993_62273279_30596_264_25_787AE7BB302AE849A7480A190F8B9330354ACDBD@OPEXCAUBMA2.corporate.adroot.infra.ftgroup> <20220308.162311.1451096198685574462.id@4668.se> <22626_1646755859_62278013_22626_395_1_787AE7BB302AE849A7480A190F8B9330354AD30F@OPEXCAUBMA2.corporate.adroot.infra.ftgroup>
In-Reply-To: <22626_1646755859_62278013_22626_395_1_787AE7BB302AE849A7480A190F8B9330354AD30F@OPEXCAUBMA2.corporate.adroot.infra.ftgroup>
Accept-Language: fr-FR, en-US
Content-Language: fr-FR
X-MS-Has-Attach:
X-MS-TNEF-Correlator:
msip_labels: MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_Enabled=true; MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_SetDate=2022-03-25T06:51:45Z; MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_Method=Privileged; MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_Name=unrestricted_parent.2; MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_SiteId=90c7a20a-f34b-40bf-bc48-b9253b6f5d20; MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_ActionId=b36d7f40-6f86-4ea5-a1e4-5eb081a6a688; MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_ContentBits=0
x-originating-ip: [10.115.26.50]
Content-Type: text/plain; charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
MIME-Version: 1.0
Archived-At: <https://mailarchive.ietf.org/arch/msg/yang-doctors/oYJncSpOA5m4iAnjXWo8YkpcrLY>
Subject: Re: [yang-doctors] [OPSAWG] Yangdoctors early review of draft-ietf-opsawg-sap-02
X-BeenThere: yang-doctors@ietf.org
X-Mailman-Version: 2.1.29
Precedence: list
List-Id: Email list of the yang-doctors directorate <yang-doctors.ietf.org>
List-Unsubscribe: <https://www.ietf.org/mailman/options/yang-doctors>, <mailto:yang-doctors-request@ietf.org?subject=unsubscribe>
List-Archive: <https://mailarchive.ietf.org/arch/browse/yang-doctors/>
List-Post: <mailto:yang-doctors@ietf.org>
List-Help: <mailto:yang-doctors-request@ietf.org?subject=help>
List-Subscribe: <https://www.ietf.org/mailman/listinfo/yang-doctors>, <mailto:yang-doctors-request@ietf.org?subject=subscribe>
X-List-Received-Date: Fri, 25 Mar 2022 06:54:09 -0000

Hi Martin, 

FWIW, the changes discussed in this thread are now implemented in the draft: https://datatracker.ietf.org/doc/html/draft-ietf-opsawg-sap-03

Cheers,
Med

> -----Message d'origine-----
> De : mohamed.boucadair@orange.com <mohamed.boucadair@orange.com>
> Envoyé : mardi 8 mars 2022 17:11
> À : Martin Björklund <mbj+ietf@4668.se>
> Cc : yang-doctors@ietf.org; draft-ietf-opsawg-sap.all@ietf.org;
> opsawg@ietf.org
> Objet : RE: [OPSAWG] Yangdoctors early review of draft-ietf-opsawg-sap-
> 02
> 
> Re-,
> 
> Sure. We will add a note about that.
> 
> Thank you for the follow-up.
> 
> Cheers,
> Med
> 
> > -----Message d'origine-----
> > De : Martin Björklund <mbj+ietf@4668.se> Envoyé : mardi 8 mars 2022
> > 16:23 À : BOUCADAIR Mohamed INNOV/NET <mohamed.boucadair@orange.com>
> > Cc : yang-doctors@ietf.org; draft-ietf-opsawg-sap.all@ietf.org;
> > opsawg@ietf.org
> > Objet : Re: [OPSAWG] Yangdoctors early review of
> > draft-ietf-opsawg-sap-
> > 02
> >
> > Hi,
> >
> > Trimming...
> >
> >
> > <mohamed.boucadair@orange.com> wrote:
> >
> > [...]
> >
> > > > -----Message d'origine-----
> > > > De : OPSAWG <opsawg-bounces@ietf.org> De la part de Martin
> > > > Björklund via Datatracker Envoyé : mardi 8 mars 2022 09:43 À :
> > > > yang-doctors@ietf.org Cc : draft-ietf-opsawg-sap.all@ietf.org;
> > > > opsawg@ietf.org Objet : [OPSAWG] Yangdoctors early review of
> > > > draft-ietf-opsawg-sap-02
> > > >
> > > > Reviewer: Martin Björklund
> >
> > [...]
> >
> > > > o  "interface-type"
> > > >
> > > >   It is not clear to me how this relates to the
> > > >   "/interfaces/interface/type" from RFC 8343.  How are the
> interface
> > > >   types defined in iana-if-type mapped to the types defined in
> this
> > > >   document?  Perhaps they are not?
> > > >
> > > >
> > >
> > > [Med] We have considered in the past the use of 8343/7224, but we
> > > went finally with the current approach as we want to cover a limited
> > > set of things such as bridge domains, bearer references, IRBs, etc.
> > > that we are already using in other service modules. The mapping to
> > > the detailed interface types as per 7224 will be made by an
> > > orchestrator when it translates this network module into devices
> modules.
> >
> > Ok.  Perhaps you can add a few lines of text that explains this in the
> > document.
> >
> >
> > /martin
> >
> 
> 
> ________________________________________________________________________
> _________________________________________________
> 
> Ce message et ses pieces jointes peuvent contenir des informations
> confidentielles ou privilegiees et ne doivent donc pas etre diffuses,
> exploites ou copies sans autorisation. Si vous avez recu ce message par
> erreur, veuillez le signaler a l'expediteur et le detruire ainsi que les
> pieces jointes. Les messages electroniques etant susceptibles
> d'alteration, Orange decline toute responsabilite si ce message a ete
> altere, deforme ou falsifie. Merci.
> 
> This message and its attachments may contain confidential or privileged
> information that may be protected by law; they should not be
> distributed, used or copied without authorisation.
> If you have received this email in error, please notify the sender and
> delete this message and its attachments.
> As emails may be altered, Orange is not liable for messages that have
> been modified, changed or falsified.
> Thank you.


_________________________________________________________________________________________________________________________

Ce message et ses pieces jointes peuvent contenir des informations confidentielles ou privilegiees et ne doivent donc
pas etre diffuses, exploites ou copies sans autorisation. Si vous avez recu ce message par erreur, veuillez le signaler
a l'expediteur et le detruire ainsi que les pieces jointes. Les messages electroniques etant susceptibles d'alteration,
Orange decline toute responsabilite si ce message a ete altere, deforme ou falsifie. Merci.

This message and its attachments may contain confidential or privileged information that may be protected by law;
they should not be distributed, used or copied without authorisation.
If you have received this email in error, please notify the sender and delete this message and its attachments.
As emails may be altered, Orange is not liable for messages that have been modified, changed or falsified.
Thank you.